Citadel Advisors’s Biomerica BMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRA
BFCFS
Citadel Advisors's BMRA Position: Q3 2026 in Review
Citadel Advisors opened a new position in Biomerica (BMRA) in Q3 2026: 12,072 shares worth $27.3K. The stake represents ﹤0.01% of the portfolio and ranks #13612 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BMRA as recently as Q1 2024.
Citadel Advisors first reported a position in BMRA in Q1 2019 and has held it in 10 quarters since. The position peaked at $155K in Q4 2022. 21 funds tracked by Wall St. Rank hold BMRA as of Q3 2026.
- Citadel Advisors held 12,072 shares of Biomerica worth $27.3K as of Q3 2026.
- Biomerica was a new Citadel Advisors position in Q3 2026.
- Biomerica made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #13612 holding.
- Citadel Advisors first reported a position in Biomerica in Q1 2019 and has held it in 10 quarters since.
- Citadel Advisors's Biomerica position peaked at $155K in Q4 2022.
- 21 funds tracked by Wall St. Rank held Biomerica as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.